Lucas Christian, Aly Samia, Touboul Chantal, Sellami Rahma, Guillaume Xavier, Garcia Gilles
Centre d'Evaluation et de Traitement de la Douleur, Service de Neurochirurgie, Hôpital Salengro, CHRU de Lille, Lille, France.
Novartis Pharma, Rueil-Malmaison, France.
Patient Relat Outcome Meas. 2020 Feb 7;11:27-37. doi: 10.2147/PROM.S222597. eCollection 2020.
Migraine and asthma are two frequent, disabling, chronic disorders with a major impact on patient well-being. The objectives of this study were to compare subjective well-being between patients with severe forms of migraine or asthma using a panel of PROs.
Adult patients were recruited during routine consultations with chest physicians or neurologists. Patients with severe migraine (reporting headaches on ≥8 days/month and having failed ≥2 prophylactic treatments) and patients with severe asthma (according to the 2017 GINA definition: requiring Step 4 or 5 treatment or presenting uncontrolled symptoms) were eligible. Each patient completed the EuroQol Questionnaire (EQ-5D-5L), the Work Productivity and Activity Impairment Questionnaire (WPAI) and the Hospital Anxiety and Depression scale (HAD). Patients with severe migraine the 6-item Headache Impact Test (HIT-6) and those with severe asthma completed the Asthma Control Test (ACT).
249 patients with severe migraine and 96 with severe asthma were enrolled. Mean EQ-5D-5L utility scores were significantly higher in the severe migraine group than in the severe asthma group (0.75±0.25 vs 0.68±0.26; <0.01). Low EQ-5D-5L utility scores were associated with frequent (≥15 headache days/month) or disabling (HIT-6 score ≥60) headaches and with poor asthma control. Patients with severe migraine more frequently presented a HAD depression score ≥11 (23.0% in severe migraine; 7.5% in severe asthma; <0.01), whereas those with severe asthma more frequently reported problems with mobility, self-care and usual activities. Absenteeism (percent worktime missed) was similar in both groups (severe migraine: 9.0%±19.1%; severe asthma: 13.8%±22.9%) but work impairment was higher in the severe migraine group (44.3% vs 28.4%; <0.01).
Quality of life, work activity and psychological distress are all deteriorated in both severe migraine and severe asthma. Different aspects are affected in the two diseases: a greater impact on psychological aspects in severe migraine and a greater impact on physical aspects in severe asthma.
偏头痛和哮喘是两种常见的、致残性的慢性疾病,对患者的健康有重大影响。本研究的目的是使用一组患者报告结局(PROs)比较重度偏头痛或哮喘患者的主观幸福感。
在与胸科医生或神经科医生的常规会诊期间招募成年患者。重度偏头痛患者(每月头痛≥8天且至少2种预防性治疗失败)和重度哮喘患者(根据2017年全球哮喘防治创议(GINA)定义:需要第4或5级治疗或存在症状控制不佳)符合条件。每位患者完成欧洲生活质量问卷(EQ-5D-5L)、工作效率和活动障碍问卷(WPAI)以及医院焦虑抑郁量表(HAD)。重度偏头痛患者完成6项头痛影响测试(HIT-6),重度哮喘患者完成哮喘控制测试(ACT)。
纳入249例重度偏头痛患者和96例重度哮喘患者。重度偏头痛组的平均EQ-5D-5L效用得分显著高于重度哮喘组(0.75±0.25对0.68±0.26;<0.01)。EQ-5D-5L效用得分低与频繁(每月≥15天头痛)或致残性(HIT-6得分≥60)头痛以及哮喘控制不佳有关。重度偏头痛患者更常出现HAD抑郁得分≥11(重度偏头痛患者中为23.0%;重度哮喘患者中为7.5%;<0.01),而重度哮喘患者更常报告行动、自我护理和日常活动方面的问题。两组的缺勤率(错过的工作时间百分比)相似(重度偏头痛:9.0%±19.1%;重度哮喘:13.8%±22.9%),但重度偏头痛组的工作障碍更高(44.3%对28.4%;<0.01)。
重度偏头痛和重度哮喘患者的生活质量、工作活动和心理困扰均恶化。两种疾病影响的方面不同:重度偏头痛对心理方面影响更大,重度哮喘对身体方面影响更大。